Personal tools

Coexpression cluster:C3998

From FANTOM5_SSTAR

Jump to: navigation, search


Full id: C3998_merkel_neuroepithelioma_small_medulloblastoma_acute_Hodgkin_retinoblastoma



Phase1 CAGE Peaks

  Short description
Hg19::chr1:840185..840202,+ p@chr1:840185..840202
+
Hg19::chr1:840205..840230,+ p@chr1:840205..840230
+
Hg19::chr1:840237..840249,+ p@chr1:840237..840249
+


Enriched pathways on this co-expression clusterSummary:
Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.
Analyst: Emmanuel Dimont

link to source dataset
data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression clusterSummary: Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter.
Analyst: Erik Arner

link to source dataset
data


No GOStat results

Enriched sample ontology terms on this co-expression clusterSummary:To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. Analyst: Hideya Kawaji

links to source dataset



disease_data


Disease
Ontology termp-valuen
cancer3.45e-13235
disease of cellular proliferation3.45e-12239
cell type cancer6.04e-12143
neuroectodermal tumor4.81e-0810
sarcoma1.40e-0720


Overrepresented TFBS (DNA) motifs on this co-expression clusterSummary:The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. Analyst: Michiel de Hoon

link to source data
Novel motifs
data

Jaspar motifs
data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)
MA0003.12.61626
MA0004.10.826076
MA0006.11.5435
MA0007.10.804807
MA0009.11.3275
MA0014.10.118426
MA0017.10.686276
MA0019.10.990656
MA0024.11.21731
MA0025.11.46617
MA0027.12.95767
MA0028.10.658629
MA0029.11.23771
MA0030.11.22561
MA0031.11.15713
MA0038.10.94098
MA0040.11.24388
MA0041.10.847069
MA0042.10.810843
MA0043.11.32783
MA0046.11.31611
MA0048.10.341392
MA0050.10.81185
MA0051.10.936307
MA0052.11.24796
MA0055.10.190716
MA0056.10
MA0057.10.333427
MA0058.10.716037
MA0059.11.70014
MA0060.10.492218
MA0061.10.456531
MA0063.10
MA0066.10.941452
MA0067.11.65513
MA0068.10.405474
MA0069.11.31207
MA0070.11.30033
MA0071.10.897953
MA0072.11.29561
MA0073.10.0185922
MA0074.10.935474
MA0076.10.734647
MA0077.11.28751
MA0078.11.04495
MA0081.10.714712
MA0083.11.33535
MA0084.11.84562
MA0087.11.29304
MA0088.10.257905
MA0089.10
MA0090.10.751469
MA0091.10.829044
MA0092.10.785956
MA0093.10.642957
MA0095.10
MA0098.10
MA0100.10.956299
MA0101.11.55947
MA0103.10.628063
MA0105.10.31555
MA0106.10.986396
MA0107.10.556367
MA0108.21.15387
MA0109.10
MA0111.10.767139
MA0113.11.00436
MA0114.10.549955
MA0115.11.57693
MA0116.10.560723
MA0117.11.36676
MA0119.10.695578
MA0122.11.39371
MA0124.11.53432
MA0125.11.44766
MA0130.10
MA0131.11.06461
MA0132.10
MA0133.10
MA0135.11.35921
MA0136.10.948776
MA0139.13.97071
MA0140.10.894983
MA0141.10.712476
MA0142.11.12317
MA0143.11.00455
MA0144.10.531867
MA0145.10.752137
MA0146.15.33893
MA0147.123.1463
MA0148.10.854239
MA0149.10.884158
MA0062.21.9924
MA0035.20.894194
MA0039.20.0526989
MA0138.21.04628
MA0002.20.476938
MA0137.20.666381
MA0104.210.807
MA0047.20.973066
MA0112.20.264678
MA0065.20.277623
MA0150.10.744617
MA0151.10
MA0152.10.902317
MA0153.11.43021
MA0154.10.312019
MA0155.10.256269
MA0156.10.669101
MA0157.11.09377
MA0158.10
MA0159.10.565904
MA0160.10.871361
MA0161.10
MA0162.10.455568
MA0163.10.122425
MA0164.11.01792
MA0080.20.643061
MA0018.20.987913
MA0099.20.902716
MA0079.27.52072
MA0102.21.88331
MA0258.10.519674
MA0259.10.575594
MA0442.10



ENCODE TF ChIP-seq peak enrichment analysisSummary: For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained.
Analyst: Erik Arner

link to source dataset

data


(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)

TF#promotersEnrichmentp-valueq-value
BCL3#602334.54710280373832.42397750207122e-050.000527302200247482
BCLAF1#9774321.65264761012189.8473954032885e-050.00139281165834784
CCNT2#90536.336201576962630.003930750035764890.0190250997768676
CHD2#1106310.34402283411690.0009033701102746880.00660832604517603
CTCF#1066435.360256373075030.0064925092527670.0279766957069659
CTCFL#140690319.74647435897440.0001298372005551160.00171972953567227
E2F6#187635.017155731697390.00791769806886330.0322661334717502
EGR1#195834.988179094810140.008056488137383440.0321026922770007
ELF1#199734.258097958807540.01295179875054610.0462847873296247
ETS1#211339.728760922202340.001085840092584840.00763098401382597
FOSL1#8061339.7135797163731.59554825631833e-050.000371461133173496
GABPB1#255337.067683836182170.002832212825417420.0154276052403781
GTF2F1#2962312.73966087675770.0004835525047438590.00434460943246248
HMGN3#932438.178547723350590.001827766942164210.0108825124948799
MAX#414936.452555509007120.003721913834265510.0186764502444076
MYC#460935.22228187160940.007020843755740150.0294868661682449
PAX5#507936.669565531177830.003370290999677260.0173070027394677
RAD21#5885310.35503389545630.0009004912073565420.0066468585203979
REST#597839.650028716128020.001112636247114590.00768485001074007
SETDB1#9869340.32002617801051.52461559299059e-050.000359109896067533
SIN3A#2594235.408884726815140.006318961977991520.0277136887422608
SMC3#9126315.04493284493280.0002935825420371870.00309368046693792
SPI1#668838.204323508522730.001810593189410520.0109152933565484
TAF7#6879311.43306940492390.0006690181981945830.00543747794562211
THAP1#55145331.36914460285133.23800758564397e-050.000647595316424877
USF1#739136.361499277207960.00388404057290560.0190524312335582
YY1#752834.911170749853860.008441455341808260.0329773754186845
ZBTB7A#5134137.35190930787590.002516255860282270.0140374577101661
ZNF143#7702313.50087655222790.0004062804962997170.00389458731097257
ZNF263#1012738.221841637010680.001799043925565870.0109537893396009



Relative expression of the co-expression clusterSummary:Co-expression clusters are compared against FANTOM5 samples to obtain relative expression.
Analyst:NA

link to data source
data


This analysis result is provided for C0 - C305 clusters.